Swiss Biotech Company May Have Produced First Cure For Cancer

The Swiss company Novartis has introduced a new drug to treat large B-cell lymphoma, which makes up 30% of lymphoma cases, and the new drug has been given the FDA’s coveted “breakthrough label.” This label means that, because the drug is meant to treat a serious or life-threatening illness, and because it has been shown to be effective in trials, the process for approving it by the FDA has been expedited. Novartis is in competition…

"Swiss Biotech Company May Have Produced First Cure For Cancer"